Key result
Arrhythmia-associated calmodulin variants disrupt KCNQ1 function through various mechanisms, including a 2.6-fold reduction in binding affinity for the E46K variant and altered membrane trafficking.
Why the study?
Little is known about how arrhythmia-associated calmodulin variants interact with KCNQ1 or affect its function, which is critical for mechanistically understanding calmodulin variant-associated arrhythmias.
Do arrhythmia-associated calmodulin variants alter KCNQ1 binding, membrane trafficking, and function compared to wild-type calmodulin?
Do arrhythmia-associated calmodulin variants alter KCNQ1 binding, membrane trafficking, and function compared to wild-type calmodulin?
Arrhythmia-associated calmodulin variants contribute to a pro-arrhythmic substrate by causing abnormal KCNQ1 membrane trafficking and current conduction, with effects ranging from benign to significant loss of function.
May guide variant-specific arrhythmia risk assessment in calmodulinopathy; hypothesis-generating and requires clinical validation.
Rationale Missense variants in calmodulin (CaM) predispose patients to arrhythmias associated with high mortality rates. As CaM regulates several key cardiac ion channels, a mechanistic understanding of CaM variant-associated arrhythmias requires elucidating individual CaM variant effect on distinct channels. One key CaM regulatory target is the KCNQ1 (K V 7.1) voltage-gated potassium channel that underlie the I Ks current. Yet, relatively little is known as to how CaM variants interact with KCNQ1 or affect its function. Objective To observe how arrhythmia-associated CaM variants affect binding to KCNQ1, channel membrane trafficking, and KCNQ1 function. Methods and Results We combine a live-cell FRET binding assay, fluorescence trafficking assay, and functional electrophysiology to characterize >10 arrhythmia-associated CaM variants effect on KCNQ1. We identify one variant (G114W) that exhibits severely weakened binding to KCNQ1 but find that most other CaM variants interact with similar binding affinity to KCNQ1 when compared to CaM wild-type over physiological Ca 2+ ranges. We further identify several CaM variants that affect KCNQ1 and I Ks membrane trafficking and/or baseline current activation kinetics, thereby contextualizing KCNQ1 dysfunction in calmodulinopathy. Lastly, we delineate CaM variants with no effect on KCNQ1 function. Conclusions This study provides comprehensive functional data that reveal how CaM variants contribute to creating a pro-arrhythmic substrate by causing abnormal KCNQ1 membrane trafficking and current conduction. We find that CaM variant regulation of KCNQ1 is not uniform with effects varying from benign to significant loss of function. This study provides a new approach to collecting details of CaM binding that are key for understanding how CaM variants predispose patients to arrhythmia via the dysregulation of multiple cardiac ion channels.
No takes yet. Share an insight, caveat, or question.
Kang et al. (2023) studied Arrhythmia (Calmodulinopathy). Arrhythmia-associated Calmodulin (CaM) variants vs. Wild-type Calmodulin (CaM WT) was evaluated on Binding affinity (KD,Eff), membrane trafficking efficiency, and current activation kinetics of KCNQ1. Arrhythmia-associated calmodulin variants disrupt KCNQ1 function through various mechanisms, including a 2.6-fold reduction in binding affinity for the E46K variant and altered membrane trafficking.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: